These lab-built choices weren't designed with recreational use in mind. In the 1990s, John W. Huffman and a team of fellow chemists at Clemson College created several of the first formulation for synthetic cannabinoid receptor agonists (SCRAs), a relatives of substances that imitate the physiological and psychological impacts of cannabis on our uni